Malnutrition

Malnutrition is a clinical condition that occurs when there is an imbalance in the energy, protein, or other components of the diet, leading to adverse effects on the body’s health. This condition encompasses undernutrition, overnutrition, and vitamin and mineral deficiencies. Undernutrition is the most common form of malnutrition and is classified based on different grading systems used worldwide. Severe undernutrition is characterized by a weight of less than 70-75% of the expected weight for age and a BMI of less than 16 kg/m2.

To grade the severity of protein-energy malnutrition (PEM), a scale is commonly used. This scale considers the expected weight for age and BMI. A normal weight is between 90-110% of the expected weight for age and a BMI of 19-24 kg/m2. Mild undernutrition is between 85-90% of the expected weight for age and a BMI of 18-18.9 kg/m2. Moderate undernutrition is between 75-85% of the expected weight for age and a BMI of 16-17.9 kg/m2. Severe undernutrition is less than 75% of the expected weight for age and a BMI of less than 16 kg/m2.

In summary, malnutrition is a serious condition that affects many people worldwide. the different types of malnutrition and their severity can help healthcare professionals provide appropriate treatment and interventions to improve the health outcomes of those affected.

The division of the truncus arteriosus into the aorta and pulmonary trunk is dependent on the migration of neural crest cells from the pharyngeal arches. If this process is disrupted, it can lead to Tetralogy of Fallot, which is likely the condition that the patient in question is experiencing. The patient’s frequent ‘tet’ spells and adoption of a squatting position are indicative of this condition, as is the boot-shaped heart seen on chest x-ray due to right ventricular hypertrophy. Other conditions that can result from failed neural crest cell migration include transposition of the great vessels and persistent truncus arteriosus.

On the other hand, a VSD is associated with a failure of the endocardial cushion, but this would not explain all of the patient’s malformations. Similarly, defects in the ostium primum or secundum would result in an ASD, which is often asymptomatic.

During cardiovascular embryology, the heart undergoes significant development and differentiation. At around 14 days gestation, the heart consists of primitive structures such as the truncus arteriosus, bulbus cordis, primitive atria, and primitive ventricle. These structures give rise to various parts of the heart, including the ascending aorta and pulmonary trunk, right ventricle, left and right atria, and majority of the left ventricle. The division of the truncus arteriosus is triggered by neural crest cell migration from the pharyngeal arches, and any issues with this migration can lead to congenital heart defects such as transposition of the great arteries or tetralogy of Fallot. Other structures derived from the primitive heart include the coronary sinus, superior vena cava, fossa ovalis, and various ligaments such as the ligamentum arteriosum and ligamentum venosum. The allantois gives rise to the urachus, while the umbilical artery becomes the medial umbilical ligaments and the umbilical vein becomes the ligamentum teres hepatis inside the falciform ligament. Overall, cardiovascular embryology is a complex process that involves the differentiation and development of various structures that ultimately form the mature heart.

The Vaughan Williams Classification of Antiarrhythmics

The Vaughan Williams classification is a widely used system for categorizing antiarrhythmic drugs based on their mechanism of action. The classification system is divided into four classes, each with a different mechanism of action. Class I drugs block sodium channels, Class II drugs are beta-adrenoceptor antagonists, Class III drugs block potassium channels, and Class IV drugs are calcium channel blockers.

Class Ia drugs, such as quinidine and procainamide, increase the duration of the action potential by blocking sodium channels. However, quinidine toxicity can cause cinchonism, which is characterized by symptoms such as headache, tinnitus, and thrombocytopenia. Procainamide may also cause drug-induced lupus.

Class Ib drugs, such as lidocaine and mexiletine, decrease the duration of the action potential by blocking sodium channels. Class Ic drugs, such as flecainide and propafenone, have no effect on the duration of the action potential but still block sodium channels.

Class II drugs, such as propranolol and metoprolol, are beta-adrenoceptor antagonists that decrease the heart rate and contractility of the heart.

Class III drugs, such as amiodarone and sotalol, block potassium channels, which prolongs the duration of the action potential.

Class IV drugs, such as verapamil and diltiazem, are calcium channel blockers that decrease the influx of calcium ions into the heart, which slows down the heart rate and reduces contractility.

It should be noted that some common antiarrhythmic drugs, such as adenosine, atropine, digoxin, and magnesium, are not included in the Vaughan Williams classification.

Vitamin C, also known as ascorbic acid, can assist in the absorption of iron from the gastrointestinal tract by converting Fe3+ to Fe2+. This is due to the acidic nature of vitamin C, which lowers the pH of the stomach and aids in the reduction of iron from its ferric to ferrous form. The ferrous form is more easily absorbed by the mucosal cells of the duodenum. On the other hand, milk and tea can hinder iron absorption, while fish oil has no known interactions with iron. It is recommended to take iron supplements separately from other medications to avoid any potential interactions.

Iron Metabolism: Absorption, Distribution, Transport, Storage, and Excretion

Iron is an essential mineral that plays a crucial role in various physiological processes. The absorption of iron occurs mainly in the upper small intestine, particularly the duodenum. Only about 10% of dietary iron is absorbed, and ferrous iron (Fe2+) is much better absorbed than ferric iron (Fe3+). The absorption of iron is regulated according to the body’s need and can be increased by vitamin C and gastric acid. However, it can be decreased by proton pump inhibitors, tetracycline, gastric achlorhydria, and tannin found in tea.

The total body iron is approximately 4g, with 70% of it being present in hemoglobin, 25% in ferritin and haemosiderin, 4% in myoglobin, and 0.1% in plasma iron. Iron is transported in the plasma as Fe3+ bound to transferrin. It is stored in tissues as ferritin, and the lost iron is excreted via the intestinal tract following desquamation.

In summary, iron metabolism involves the absorption, distribution, transport, storage, and excretion of iron in the body. Understanding these processes is crucial in maintaining iron homeostasis and preventing iron-related disorders.

The epidermis comprises five distinct layers that consist of various cell types and perform different functions. These layers, listed from outermost to innermost, are the stratum corneum, stratum lucidum*, and stratum granulosum.

The Layers of the Epidermis

The epidermis is the outermost layer of the skin and is made up of a stratified squamous epithelium with a basal lamina underneath. It can be divided into five layers, each with its own unique characteristics. The first layer is the stratum corneum, which is made up of flat, dead, scale-like cells filled with keratin. These cells are continually shed and replaced with new ones. The second layer, the stratum lucidum, is only present in thick skin and is a clear layer. The third layer, the stratum granulosum, is where cells form links with their neighbors. The fourth layer, the stratum spinosum, is the thickest layer of the epidermis and is where squamous cells begin keratin synthesis. Finally, the fifth layer is the stratum germinativum, which is the basement membrane and is made up of a single layer of columnar epithelial cells. This layer gives rise to keratinocytes and contains melanocytes. Understanding the layers of the epidermis is important for understanding the structure and function of the skin.

Secondary hypertension is primarily caused by renal disease, while other endocrine diseases like hyperaldosteronism, phaeochromocytoma, and acromegaly are less common culprits. Malignancy and pregnancy typically do not lead to hypertension, although pregnancy can result in pre-eclampsia, which is characterized by high blood pressure. Certain medications, such as NSAIDs and glucocorticoids, can also induce hypertension.

Secondary Causes of Hypertension

Hypertension, or high blood pressure, can be caused by various factors. While primary hypertension has no identifiable cause, secondary hypertension is caused by an underlying medical condition. The most common cause of secondary hypertension is primary hyperaldosteronism, which accounts for 5-10% of cases. Other causes include renal diseases such as glomerulonephritis, pyelonephritis, adult polycystic kidney disease, and renal artery stenosis. Endocrine disorders like phaeochromocytoma, Cushing’s syndrome, Liddle’s syndrome, congenital adrenal hyperplasia, and acromegaly can also result in increased blood pressure. Certain medications like steroids, monoamine oxidase inhibitors, the combined oral contraceptive pill, NSAIDs, and leflunomide can also cause hypertension. Pregnancy and coarctation of the aorta are other possible causes. Identifying and treating the underlying condition is crucial in managing secondary hypertension.

Elbow extension will remain unaffected as the triceps are not impacted. However, the most noticeable consequence will be the loss of wrist extension.

The Radial Nerve: Anatomy, Innervation, and Patterns of Damage

The radial nerve is a continuation of the posterior cord of the brachial plexus, with root values ranging from C5 to T1. It travels through the axilla, posterior to the axillary artery, and enters the arm between the brachial artery and the long head of triceps. From there, it spirals around the posterior surface of the humerus in the groove for the radial nerve before piercing the intermuscular septum and descending in front of the lateral epicondyle. At the lateral epicondyle, it divides into a superficial and deep terminal branch, with the deep branch crossing the supinator to become the posterior interosseous nerve.

The radial nerve innervates several muscles, including triceps, anconeus, brachioradialis, and extensor carpi radialis. The posterior interosseous branch innervates supinator, extensor carpi ulnaris, extensor digitorum, and other muscles. Denervation of these muscles can lead to weakness or paralysis, with effects ranging from minor effects on shoulder stability to loss of elbow extension and weakening of supination of prone hand and elbow flexion in mid prone position.

Damage to the radial nerve can result in wrist drop and sensory loss to a small area between the dorsal aspect of the 1st and 2nd metacarpals. Axillary damage can also cause paralysis of triceps. Understanding the anatomy, innervation, and patterns of damage of the radial nerve is important for diagnosing and treating conditions that affect this nerve.

The medial longitudinal fasciculus is situated in the paramedian region of the midbrain and pons.

The patient’s symptoms are indicative of internuclear ophthalmoplegia (INO), a specific gaze abnormality characterized by impaired adduction of the eye on the affected side and nystagmus of the eye on the opposite side of the lesion. Based on the symptoms, the lesion is likely on the right side. INO is caused by damage to the medial longitudinal fasciculus, which coordinates the simultaneous lateral movements of both eyes. Multiple sclerosis is a common cause of this condition, but cerebrovascular disease is also associated with it, especially in older patients.

Optic neuritis, a common manifestation of multiple sclerosis, is not responsible for the patient’s symptoms. Optic neuritis typically presents with eye pain, visual acuity loss, and worsened pain on eye movement, which are not mentioned in the scenario.

Distinguishing between internuclear ophthalmoplegia and oculomotor (third) nerve palsy can be challenging. Symptoms that suggest CN III palsy include ptosis, pupil dilation, and weakness of elevation, which causes the eye to rest in a ‘down and out’ position. Clinical examination findings can help differentiate between trochlear or abducens nerve palsy and internuclear ophthalmoplegia. Abducens nerve damage results in unilateral weakness of the lateral rectus muscle and impaired abduction on the affected side, while trochlear nerve damage leads to unilateral weakness of the superior oblique muscle and impaired intorsion and depression when adducted.

Understanding Internuclear Ophthalmoplegia

Internuclear ophthalmoplegia is a condition that affects the horizontal movement of the eyes. It is caused by a lesion in the medial longitudinal fasciculus (MLF), which is responsible for interconnecting the IIIrd, IVth, and VIth cranial nuclei. This area is located in the paramedian region of the midbrain and pons. The main feature of this condition is impaired adduction of the eye on the same side as the lesion, along with horizontal nystagmus of the abducting eye on the opposite side.

The most common causes of internuclear ophthalmoplegia are multiple sclerosis and vascular disease. It is important to note that this condition can also be a sign of other underlying neurological disorders.

Aminoglycosides have the potential to cause kidney damage.

Gentamicin, a powerful antibiotic belonging to the aminoglycoside class, is known to have serious adverse effects such as damage to the kidneys and ears. Therefore, before starting treatment with aminoglycosides, the patient’s kidney function is evaluated.

Cholestatic jaundice is a common side effect associated with the use of co-amoxiclav and flucloxacillin. Ceftriaxone can lead to the formation of deposits in the gallbladder.

Gentamicin is a type of antibiotic known as an aminoglycoside. It is not easily dissolved in lipids, so it is typically administered through injection or topical application. It is commonly used to treat infections such as infective endocarditis and otitis externa. However, gentamicin can have adverse effects on the body, such as ototoxicity, which can cause damage to the auditory or vestibular nerves. This damage is irreversible. Gentamicin can also cause nephrotoxicity, which can lead to acute tubular necrosis. The risk of toxicity increases when gentamicin is used in conjunction with furosemide. Lower doses and more frequent monitoring are necessary to prevent these adverse effects. Gentamicin is contraindicated in patients with myasthenia gravis. To ensure safe dosing, plasma concentrations of gentamicin are monitored. Peak levels are measured one hour after administration, and trough levels are measured just before the next dose. If the trough level is high, the interval between doses should be increased. If the peak level is high, the dose should be decreased.

The TP53 gene, which encodes the protein p53, is crucial in preventing the cell cycle from entering the S phase until DNA has been checked and repaired. This is particularly important in individuals with Li-Fraumeni syndrome (LFS), an inherited susceptibility to cancer that often results in the development of multiple sarcomas from a young age. LFS is caused by a mutation in one allele of the TP53 gene. One of the key functions of p53 is to hold the cell cycle at the G1/S checkpoint, allowing for the detection and repair of any DNA damage before replication occurs.

The identification of double-strand DNA breaks is not a function of p53. This is typically carried out by the MRN protein complex, which acts upstream of DNA repair proteins such as BRCA1 and BRCA2.

Inhibition of apoptosis is also not a primary function of p53. While p53 can promote apoptosis if cell cycle checkpoints are not satisfied, its primary role is in regulating the cell cycle.

Similarly, mismatch repair of single-strand DNA breaks is not a function of p53. This is typically carried out by mismatch repair proteins such as MLH-1 and MSH-2, which may be mutated in the familial cancer syndrome Lynch syndrome.

Understanding p53 and its Role in Cancer

p53 is a gene that helps suppress tumours and is located on chromosome 17p. It is frequently mutated in breast, colon, and lung cancer. The gene is believed to be essential in regulating the cell cycle, preventing cells from entering the S phase until DNA has been checked and repaired. Additionally, p53 may play a crucial role in apoptosis, the process of programmed cell death.

Li-Fraumeni syndrome is a rare genetic disorder that is inherited in an autosomal dominant pattern. It is characterised by the early onset of various cancers, including sarcoma, breast cancer, and leukaemia. The condition is caused by mutations in the p53 gene, which can lead to a loss of its tumour-suppressing function. Understanding the role of p53 in cancer can help researchers develop new treatments and therapies for those affected by the disease.

As long as the patient’s Hb level is 7 or higher, transfusion may not be necessary for their management. However, this threshold may vary depending on individual factors such as co-existing medical conditions. It is important to avoid using old blood during massive transfusions as its effectiveness may be compromised.

Blood Products and Cell Saver Devices

Blood products are essential in various medical procedures, especially in cases where patients require transfusions due to anaemia or bleeding. Packed red cells, platelet-rich plasma, platelet concentrate, fresh frozen plasma, and cryoprecipitate are some of the commonly used whole blood fractions. Fresh frozen plasma is usually administered to patients with clotting deficiencies, while cryoprecipitate is a rich source of Factor VIII and fibrinogen. Cross-matching is necessary for all blood products, and cell saver devices are used to collect and re-infuse a patient’s own blood lost during surgery.

Cell saver devices come in two types, those that wash the blood cells before re-infusion and those that do not. The former is more expensive and complicated to operate but reduces the risk of re-infusing contaminated blood. The latter avoids the use of donor blood and may be acceptable to Jehovah’s witnesses. However, it is contraindicated in malignant diseases due to the risk of facilitating disease dissemination.

In some surgical patients, the use of warfarin can pose specific problems and may require the use of specialised blood products. Warfarin reversal can be achieved through the administration of vitamin K, fresh frozen plasma, or human prothrombin complex. Fresh frozen plasma is used less commonly now as a first-line warfarin reversal, and human prothrombin complex is preferred due to its rapid action. However, it should be given with vitamin K as factor 6 has a short half-life.

It must not include red blood cells.

Cerebrospinal Fluid: Circulation and Composition

Cerebrospinal fluid (CSF) is a clear, colorless liquid that fills the space between the arachnoid mater and pia mater, covering the surface of the brain. The total volume of CSF in the brain is approximately 150ml, and it is produced by the ependymal cells in the choroid plexus or blood vessels. The majority of CSF is produced by the choroid plexus, accounting for 70% of the total volume. The remaining 30% is produced by blood vessels. The CSF is reabsorbed via the arachnoid granulations, which project into the venous sinuses.

The circulation of CSF starts from the lateral ventricles, which are connected to the third ventricle via the foramen of Munro. From the third ventricle, the CSF flows through the cerebral aqueduct (aqueduct of Sylvius) to reach the fourth ventricle via the foramina of Magendie and Luschka. The CSF then enters the subarachnoid space, where it circulates around the brain and spinal cord. Finally, the CSF is reabsorbed into the venous system via arachnoid granulations into the superior sagittal sinus.

The composition of CSF is essential for its proper functioning. The glucose level in CSF is between 50-80 mg/dl, while the protein level is between 15-40 mg/dl. Red blood cells are not present in CSF, and the white blood cell count is usually less than 3 cells/mm3. Understanding the circulation and composition of CSF is crucial for diagnosing and treating various neurological disorders.

The Vaughan Williams Classification of Antiarrhythmics

The Vaughan Williams classification is a widely used system for categorizing antiarrhythmic drugs based on their mechanism of action. The classification system is divided into four classes, each with a different mechanism of action. Class I drugs block sodium channels, Class II drugs are beta-adrenoceptor antagonists, Class III drugs block potassium channels, and Class IV drugs are calcium channel blockers.

Class Ia drugs, such as quinidine and procainamide, increase the duration of the action potential by blocking sodium channels. However, quinidine toxicity can cause cinchonism, which is characterized by symptoms such as headache, tinnitus, and thrombocytopenia. Procainamide may also cause drug-induced lupus.

Class Ib drugs, such as lidocaine and mexiletine, decrease the duration of the action potential by blocking sodium channels. Class Ic drugs, such as flecainide and propafenone, have no effect on the duration of the action potential but still block sodium channels.

Class II drugs, such as propranolol and metoprolol, are beta-adrenoceptor antagonists that decrease the heart rate and contractility of the heart.

Class III drugs, such as amiodarone and sotalol, block potassium channels, which prolongs the duration of the action potential.

Class IV drugs, such as verapamil and diltiazem, are calcium channel blockers that decrease the influx of calcium ions into the heart, which slows down the heart rate and reduces contractility.

It should be noted that some common antiarrhythmic drugs, such as adenosine, atropine, digoxin, and magnesium, are not included in the Vaughan Williams classification.

Neuropraxia typically results in full recovery within 6-8 weeks after nerve injury, and Wallerian degeneration is not a common occurrence. Additionally, autonomic function is typically maintained.

Nerve injuries can be classified into three types: neuropraxia, axonotmesis, and neurotmesis. Neuropraxia occurs when the nerve is intact but its electrical conduction is affected. However, full recovery is possible, and autonomic function is preserved. Wallerian degeneration, which is the degeneration of axons distal to the site of injury, does not occur. Axonotmesis, on the other hand, happens when the axon is damaged, but the myelin sheath is preserved, and the connective tissue framework is not affected. Wallerian degeneration occurs in this type of injury. Lastly, neurotmesis is the most severe type of nerve injury, where there is a disruption of the axon, myelin sheath, and surrounding connective tissue. Wallerian degeneration also occurs in this type of injury.

Wallerian degeneration typically begins 24-36 hours following the injury. Axons are excitable before degeneration occurs, and the myelin sheath degenerates and is phagocytosed by tissue macrophages. Neuronal repair may only occur physiologically where nerves are in direct contact. However, nerve regeneration may be hampered when a large defect is present, and it may not occur at all or result in the formation of a neuroma. If nerve regrowth occurs, it typically happens at a rate of 1mm per day.

When assessing a pigmented lesion, it is important to consider the ‘ABCDE’ criteria: Asymmetry, Border, Colour, Diameter, and Evolution. The British Association of Dermatologists (BAD) provides guidance on this assessment. According to BAD, a diameter of over 6mm is more indicative of a melanoma than a diameter of 4mm. A lesion’s color alone does not determine malignancy, as highly pigmented lesions can be benign. Rolled edges are more commonly associated with basal cell carcinoma than melanoma. However, the presence of multiple colors within a lesion, including different shades of black, brown, and pink, is a significant indicator of melanoma.

Skin cancer is a type of cancer that affects the skin. There are three main types of skin cancer: basal cell cancer, squamous cell cancer, and malignant melanoma. The risk factors for skin cancer include sun exposure, iatrogenic factors such as PUVA and UVB phototherapy, exposure to arsenic, and immunosuppression following renal transplant. People who have undergone renal transplant are at a higher risk of developing squamous cell cancer and basal cell cancer, and this may be linked to human papillomavirus.

Skin cancer is a type of cancer that affects the skin. It can be classified into three main types: basal cell cancer, squamous cell cancer, and malignant melanoma. The risk factors for skin cancer include exposure to the sun, iatrogenic factors such as PUVA and UVB phototherapy, exposure to arsenic, and immunosuppression following renal transplant. People who have undergone renal transplant are at a higher risk of developing squamous cell cancer and basal cell cancer, and this may be linked to human papillomavirus.

Misoprostol is a medication that mimics the effects of prostaglandins, leading to the contraction of the uterus and the expulsion of fetal tissue. It is commonly used in the medical treatment of miscarriage, but it does not have any pain-relieving properties. Pain during a miscarriage is typically managed with other medications like ibuprofen, paracetamol, and codeine. Misoprostol also does not have any effect on blood loss, which is usually light and does not require treatment. In contrast, methotrexate is a medication that destroys rapidly dividing cells and is used to manage ectopic pregnancies. Finally, it’s important to note that misoprostol does not stimulate the release of oxytocin.

Drugs Used in Obstetrics and Gynaecology

Syntocinon is a synthetic form of oxytocin that is utilized in the active management of the third stage of labor. It aids in the contraction of the uterus, which reduces the risk of postpartum hemorrhage. Additionally, it is used to induce labor. Ergometrine, an ergot alkaloid, is an alternative to oxytocin in the active management of the third stage of labor. It can decrease blood loss by constricting the vascular smooth muscle of the uterus. Its mechanism of action involves stimulating alpha-adrenergic, dopaminergic, and serotonergic receptors. However, it can cause coronary artery spasm as an adverse effect.

Mifepristone is used in combination with misoprostol to terminate pregnancies. Misoprostol is a prostaglandin analog that causes uterine contractions. Mifepristone is a competitive progesterone receptor antagonist. Its mechanism of action involves blocking the effects of progesterone, which is necessary for the maintenance of pregnancy. However, it can cause menorrhagia as an adverse effect.

Lung cancer can cause the hemidiaphragm on the same side to rise due to pressure on the phrenic nerve. Haemoptysis is a common symptom of lung cancer, along with significant weight loss and a history of smoking. A chest x-ray can confirm the presence of a mediastinal mass, which is likely to be lung cancer.

A rapidly expanding lung mass can cause compression of surrounding structures, leading to complications. For example, an apical tumor can compress the brachial plexus, causing sensory symptoms in the arms or Erb’s or Klumpke’s palsies. Compression of the cervical sympathetic chain can cause Horner’s syndrome, which includes meiosis, anhidrosis, ptosis, and enophthalmos.

A mediastinal mass can also compress the recurrent laryngeal nerve as it winds around the aortic arch, resulting in hoarseness of voice or aphonia. Superior vena caval syndrome is a medical emergency that can cause swelling of the face, neck, upper chest, and arms, as well as the development of collaterals on the chest wall. Malignancy is the most common cause, but non-malignant causes can include an aortic aneurysm, fibrosing mediastinitis, or iatrogenic factors.

The Phrenic Nerve: Origin, Path, and Supplies

The phrenic nerve is a crucial nerve that originates from the cervical spinal nerves C3, C4, and C5. It supplies the diaphragm and provides sensation to the central diaphragm and pericardium. The nerve passes with the internal jugular vein across scalenus anterior and deep to the prevertebral fascia of the deep cervical fascia.

The right phrenic nerve runs anterior to the first part of the subclavian artery in the superior mediastinum and laterally to the superior vena cava. In the middle mediastinum, it is located to the right of the pericardium and passes over the right atrium to exit the diaphragm at T8. On the other hand, the left phrenic nerve passes lateral to the left subclavian artery, aortic arch, and left ventricle. It passes anterior to the root of the lung and pierces the diaphragm alone.

Understanding the origin, path, and supplies of the phrenic nerve is essential in diagnosing and treating conditions that affect the diaphragm and pericardium.

Metformin is a medication commonly used to treat type 2 diabetes mellitus, as well as polycystic ovarian syndrome and non-alcoholic fatty liver disease. Unlike other medications, such as sulphonylureas, metformin does not cause hypoglycaemia or weight gain, making it a first-line treatment option, especially for overweight patients. Its mechanism of action involves activating the AMP-activated protein kinase, increasing insulin sensitivity, decreasing hepatic gluconeogenesis, and potentially reducing gastrointestinal absorption of carbohydrates. However, metformin can cause gastrointestinal upsets, reduced vitamin B12 absorption, and in rare cases, lactic acidosis, particularly in patients with severe liver disease or renal failure. It is contraindicated in patients with chronic kidney disease, recent myocardial infarction, sepsis, acute kidney injury, severe dehydration, and those undergoing iodine-containing x-ray contrast media procedures. When starting metformin, it should be titrated up slowly to reduce the incidence of gastrointestinal side-effects, and modified-release metformin can be considered for patients who experience unacceptable side-effects.

Women with a uterus require HRT that contains a progestogen to reduce the risk of uterine cancer. The choice of HRT should be individualised based on age, symptoms, and comorbidities. Lifestyle advice should be given, but the decision to use HRT is personal. Perimenopause occurs before periods stop, and oestrogen-only HRT can be prescribed to patients without a uterus. Headaches are not a contraindication, but caution should be taken in patients with migraine. Absolute contraindications include certain cancers, vaginal bleeding, and thromboembolism. HRT should not be prescribed to pregnant patients.

Hormone Replacement Therapy: Uses and Varieties

Hormone replacement therapy (HRT) is a treatment that involves administering a small amount of estrogen, combined with a progestogen (in women with a uterus), to alleviate menopausal symptoms. The indications for HRT have changed significantly over the past decade due to the long-term risks that have become apparent, primarily as a result of the Women’s Health Initiative (WHI) study.

The most common indication for HRT is vasomotor symptoms such as flushing, insomnia, and headaches. Other indications, such as reversal of vaginal atrophy, should be treated with other agents as first-line therapies. HRT is also recommended for women who experience premature menopause, which should be continued until the age of 50 years. The most important reason for giving HRT to younger women is to prevent the development of osteoporosis. Additionally, HRT has been shown to reduce the incidence of colorectal cancer.

HRT generally consists of an oestrogenic compound, which replaces the diminished levels that occur in the perimenopausal period. This is normally combined with a progestogen if a woman has a uterus to reduce the risk of endometrial cancer. The choice of hormone includes natural oestrogens such as estradiol, estrone, and conjugated oestrogen, which are generally used rather than synthetic oestrogens such as ethinylestradiol (which is used in the combined oral contraceptive pill). Synthetic progestogens such as medroxyprogesterone, norethisterone, levonorgestrel, and drospirenone are usually used. A levonorgestrel-releasing intrauterine system (e.g. Mirena) may be used as the progestogen component of HRT, i.e. a woman could take an oral oestrogen and have endometrial protection using a Mirena coil. Tibolone, a synthetic compound with both oestrogenic, progestogenic, and androgenic activity, is another option.

HRT can be taken orally or transdermally (via a patch or gel). Transdermal is preferred if the woman is at risk of venous thromboembolism (VTE), as the rates of VTE do not appear to rise with transdermal preparations.

The Process of Energy Production from Glucose in the Human Body

The breakdown of fuel molecules, particularly glucose, is a crucial process in the human body. While fat and protein can also be used for fuel, glucose has the simplest method of metabolism. For this process to occur, nutrients from the diet must be absorbed and distributed to individual cells. Most cells in the body have the necessary machinery for producing ATP from glucose.

The process of producing energy from glucose involves three main steps. First, glycolysis occurs, where the 6-carbon glucose molecule is split into two 3-carbon particles. Next, the Kreb cycle, also known as the tricarboxylic acid cycle, modifies 3-carbon containing acids in a series of steps to produce NADH. Finally, the electron transfer chain takes place inside mitochondria, where the NADH generated during the Kreb cycle is used to produce energy in the form of ATP through a series of redox reactions.

In summary, the process of energy production from glucose is a fundamental process in the human body. It involves the breakdown of glucose into smaller particles, modification of these particles to produce NADH, and the use of NADH to produce ATP through a series of redox reactions.

Precision refers to the consistency of a test in producing the same results when repeated multiple times. It is an important aspect of test reliability and can impact the accuracy of the results. In order to assess precision, multiple tests are performed on the same sample and the results are compared. A test with high precision will produce similar results each time it is performed, while a test with low precision will produce inconsistent results. It is important to consider precision when interpreting test results and making clinical decisions.

Factor V Leiden is the most prevalent inherited thrombophilia, causing activated protein C resistance. This mutation leads to increased clotting as Factor V is less susceptible to degradation by protein C. The APTT and PT typically remain normal. Protein S deficiency is a rare thrombophilia, where the lack of protein S results in the inability to activate protein C and degrade factor V and factor VIII. Antithrombin III deficiency is another rare disorder where the absence of antithrombin III leads to unregulated thrombin. The prothrombin gene mutation is the second most common inherited thrombophilia.

Thrombophilia is a condition that causes an increased risk of blood clots. It can be inherited or acquired. Inherited thrombophilia is caused by genetic mutations that affect the body’s natural ability to prevent blood clots. The most common cause of inherited thrombophilia is a gain of function polymorphism called factor V Leiden, which affects the protein that helps regulate blood clotting. Other genetic mutations that can cause thrombophilia include deficiencies of naturally occurring anticoagulants such as antithrombin III, protein C, and protein S. The prevalence and relative risk of venous thromboembolism (VTE) vary depending on the specific genetic mutation.

Acquired thrombophilia can be caused by conditions such as antiphospholipid syndrome or the use of certain medications, such as the combined oral contraceptive pill. These conditions can affect the body’s natural ability to prevent blood clots and increase the risk of VTE. It is important to identify and manage thrombophilia to prevent serious complications such as deep vein thrombosis and pulmonary embolism.

The suprapleural membrane, also known as Sibson’s fascia, is located above the pleural cavity. The scalenus anterior muscle is positioned in front of the subclavian vein, while the subclavian artery is situated behind it.

Thoracic Outlet: Where the Subclavian Artery and Vein and Brachial Plexus Exit the Thorax

The thoracic outlet is the area where the subclavian artery and vein and the brachial plexus exit the thorax and enter the arm. This passage occurs over the first rib and under the clavicle. The subclavian vein is the most anterior structure and is located immediately in front of scalenus anterior and its attachment to the first rib. Scalenus anterior has two parts, and the subclavian artery leaves the thorax by passing over the first rib and between these two portions of the muscle. At the level of the first rib, the lower cervical nerve roots combine to form the three trunks of the brachial plexus. The lowest trunk is formed by the union of C8 and T1, and this trunk lies directly posterior to the artery and is in contact with the superior surface of the first rib.

Thoracic outlet obstruction can cause neurovascular compromise.

A surgical emergency is indicated when Charcot’s triad is present. Patients require biliary decompression and administration of broad-spectrum antibiotics. The most frequently identified organism in cholangitis infections is E. coli, with enterobacter being a less common finding.

Ascending Cholangitis: A Bacterial Infection of the Biliary Tree

Ascending cholangitis is a bacterial infection that affects the biliary tree, with E. coli being the most common culprit. The primary risk factor for this condition is gallstones. Patients with ascending cholangitis may experience Charcot’s triad, which includes fever, jaundice, and right upper quadrant pain. However, this triad is only present in 20-50% of cases. Fever is the most common symptom, occurring in 90% of patients, followed by RUQ pain (70%) and jaundice (60%). In some cases, patients may also experience hypotension and confusion, which, when combined with the other three symptoms, makeup Reynolds’ pentad.

In addition to the above symptoms, patients with ascending cholangitis may also have raised inflammatory markers. Ultrasound is typically the first-line investigation used to diagnose this condition. It is used to look for bile duct dilation and stones.

The management of ascending cholangitis involves intravenous antibiotics and endoscopic retrograde cholangiopancreatography (ERCP) after 24-48 hours to relieve any obstruction. By understanding the symptoms and risk factors associated with ascending cholangitis, healthcare providers can diagnose and treat this condition promptly, reducing the risk of complications.

Types of Hallucinations and Illusions

Functional hallucinations are auditory hallucinations that occur in response to an external stimulus. The individual can distinguish between the stimulus and the hallucination, and the hallucination only occurs when the stimulus is present. Reflex hallucinations, on the other hand, occur when a sensory stimulus in one modality causes a hallucination in another modality.

Autoscopy, also known as phantom mirror-image, is the experience of seeing oneself and recognizing that it is oneself. This can be a disorienting experience, as the individual may feel as though they are outside of their own body. Extracampine hallucinations occur when an individual experiences a hallucination outside of their own sensory field, such as seeing something behind them when they are looking straight ahead.

Auditory illusions occur when an auditory stimulus is misinterpreted by the listener. This can happen when the listener is in a noisy environment or when the sound is distorted in some way. It is important to note that hallucinations and illusions can be symptoms of various mental health conditions and should be evaluated by a medical professional.

Before and during amiodarone therapy, it is important to check thyroid and liver function tests.

Drug monitoring is an essential aspect of patient care to ensure the safe and effective use of medications. The tables below provide basic guidelines for monitoring common drugs in different therapeutic categories. It is important to note that these guidelines do not relate to monitoring the effectiveness of treatment, such as checking lipid levels for patients taking statins.

For cardiovascular drugs, statins require monitoring of liver function tests (LFTs) at baseline, 3 months, and 12 months. ACE inhibitors require monitoring of electrolytes (U&E) prior to treatment, after increasing the dose, and at least annually. Amiodarone requires monitoring of thyroid function tests (TFT), LFT, U&E, and chest X-ray prior to treatment, and TFT and LFT every 6 months.

In rheumatology, methotrexate requires monitoring of full blood count (FBC), LFT, and U&E before starting treatment, with weekly monitoring until therapy stabilizes, and then every 2-3 months. Azathioprine requires monitoring of FBC and LFT before treatment, weekly for the first 4 weeks, and every 3 months thereafter.

For neuropsychiatric drugs, lithium requires monitoring of lithium levels, TFT, and U&E prior to treatment, weekly until stabilized, and then every 3 months. TFT and U&E should be monitored every 6 months. Sodium valproate requires monitoring of LFT and FBC before treatment and periodically during the first 6 months.

Finally, for endocrine drugs, glitazones require monitoring of LFT before treatment and regularly during treatment. These guidelines serve as a starting point for drug monitoring and may be adjusted based on individual patient needs and clinical judgment.

Making Decisions for Patients without Capacity

When a patient lacks the capacity to make decisions about their care, healthcare professionals must act in their best interests. In the case of deciding when to complete a DNACPR form, the potential harm of CPR must be weighed against the distress that signing the form may cause the patient and their family. However, discussions about end-of-life care and CPR should ideally take place before a DNACPR order is signed.

It is important to note that even competent patients cannot demand medically inappropriate treatment, such as CPR. When a DNACPR order is justified on medical grounds, discussion with the patient, their power of attorney, and family is not necessary prior to signing the order. However, involving patients and their families in these discussions as early as possible is good practice.

Reference:
Resuscitation Council UK. Decisions relating to cardiopulmonary resuscitation.

Brown tumors are bone tumors that develop due to excessive osteoclast activity, typically in cases of hyperparathyroidism. These tumors are composed of fibrous tissue, woven bone, and supporting blood vessels, but lack any matrix. They do not appear on x-rays due to their radiolucent nature. Osteoclasts consume the trabecular bone that osteoblasts produce, leading to a cycle of reparative bone deposition and resorption that can cause bone pain and involve the periosteum, resulting in an expansion beyond the typical shape of the bone. The tumors are called brown due to the deposition of haemosiderin at the site.

Primary Hyperparathyroidism: Causes, Symptoms, and Treatment

Primary hyperparathyroidism is a condition that is commonly seen in elderly females and is characterized by an unquenchable thirst and an inappropriately normal or raised parathyroid hormone level. It is usually caused by a solitary adenoma, hyperplasia, multiple adenoma, or carcinoma. While around 80% of patients are asymptomatic, the symptomatic features of primary hyperparathyroidism may include polydipsia, polyuria, depression, anorexia, nausea, constipation, peptic ulceration, pancreatitis, bone pain/fracture, renal stones, and hypertension.

Primary hyperparathyroidism is associated with hypertension and multiple endocrine neoplasia, such as MEN I and II. To diagnose this condition, doctors may perform a technetium-MIBI subtraction scan or look for a characteristic X-ray finding of hyperparathyroidism called the pepperpot skull.

The definitive management for primary hyperparathyroidism is total parathyroidectomy. However, conservative management may be offered if the calcium level is less than 0.25 mmol/L above the upper limit of normal, the patient is over 50 years old, and there is no evidence of end-organ damage. Patients who are not suitable for surgery may be treated with cinacalcet, a calcimimetic that mimics the action of calcium on tissues by allosteric activation of the calcium-sensing receptor.

In summary, primary hyperparathyroidism is a condition that can cause various symptoms and is commonly seen in elderly females. It can be diagnosed through various tests and managed through surgery or medication.

Naftidrofuryl, a 5-HT2 receptor antagonist, can be used to treat peripheral vascular disease (PVD) and alleviate symptoms such as intermittent claudication. This medication works by causing vasodilation, which increases blood flow to areas of the body affected by PVD. On the other hand, drugs like doxazosin, an alpha 1 blocker, do not have a role in treating PVD. Beta blockers, which can worsen intermittent claudication by inducing vasoconstriction, are also not recommended for PVD treatment.

Managing Peripheral Arterial Disease

Peripheral arterial disease (PAD) is closely associated with smoking, and patients who still smoke should be provided with assistance to quit. Comorbidities such as hypertension, diabetes mellitus, and obesity should also be treated. All patients with established cardiovascular disease, including PAD, should be taking a statin, with atorvastatin 80 mg currently recommended. In 2010, NICE recommended clopidogrel as the first-line treatment for PAD patients over aspirin.

Exercise training has been shown to have significant benefits, and NICE recommends a supervised exercise program for all PAD patients before other interventions. Severe PAD or critical limb ischaemia may be treated with endovascular or surgical revascularization, with endovascular techniques typically used for short segment stenosis, aortic iliac disease, and high-risk patients. Surgical techniques are typically used for long segment lesions, multifocal lesions, lesions of the common femoral artery, and purely infrapopliteal disease. Amputation should be reserved for patients with critical limb ischaemia who are not suitable for other interventions such as angioplasty or bypass surgery.

Drugs licensed for use in PAD include naftidrofuryl oxalate, a vasodilator sometimes used for patients with a poor quality of life, and cilostazol, a phosphodiesterase III inhibitor with both antiplatelet and vasodilator effects, which is not recommended by NICE.

Genetics of Haematological Malignancies

Haematological malignancies are cancers that affect the blood, bone marrow, and lymphatic system. These cancers are often associated with specific genetic abnormalities, such as translocations. Here are some common translocations and their associated haematological malignancies:

– Philadelphia chromosome (t(9;22)): This translocation is present in more than 95% of patients with chronic myeloid leukaemia (CML). It results in the fusion of the Abelson proto-oncogene with the BCR gene on chromosome 22, creating the BCR-ABL gene. This gene codes for a fusion protein with excessive tyrosine kinase activity, which is a poor prognostic indicator in acute lymphoblastic leukaemia (ALL).

– t(15;17): This translocation is seen in acute promyelocytic leukaemia (M3) and involves the fusion of the PML and RAR-alpha genes.

– t(8;14): Burkitt’s lymphoma is associated with this translocation, which involves the translocation of the MYC oncogene to an immunoglobulin gene.

– t(11;14): Mantle cell lymphoma is associated with the deregulation of the cyclin D1 (BCL-1) gene.

– t(14;18): Follicular lymphoma is associated with increased BCL-2 transcription due to this translocation.

Understanding the genetic abnormalities associated with haematological malignancies is important for diagnosis, prognosis, and treatment.